NTHI logo

Neonc Technologies Holdings, Inc.

NTHI
Healthcare|Biotechnology|US
$3.49
+0.29 (+9.06%)
Cash / Share
$0.24

Financials

Financial Snapshot

Market Cap
$100.5M
Enterprise Value
$94.7M
Revenue (TTM)
$0.00
Net Income (TTM)
-$45.9M
Cash & Investments
$6.2M
Net Cash
$5.9M
Free Cash Flow (TTM)
-$20.4M
Operating CF (TTM)
-$20.4M
Debt/Equity
-0.02

Cash Runway & Burn Rate

Cash on Hand
$6.2M
Quarterly Burn
$5.1M
Monthly Burn
$1.7M
Est. Runway
~1.2 quarters
MetricTrend2025TTM
Cash & Investments
$58.7K$6.2M
Operating Cash Flow
-$20.4M-$20.4M
Free Cash Flow
-$20.9M-$20.4M
Capital Expenditure
-$500.0K$0.00
Financing Cash Flow
$20.9M$25.6M

R&D Spending

R&D (TTM)
$6.5M
R&D Intensity
—
R&D Growth vs Prior
+78.4%
MetricTrend2025TTM
Revenue
$40.0K$0.00
R&D Expense
$3.6M$6.5M
R&D % of Revenue9097.9%—
SG&A
$42.9M$30.2M

Income Statement

MetricTrend2025TTM
Revenue
$40.0K$0.00
Cost of Revenue
$0.00$57.5K
Gross Profit
$40.0K-$57.5K
R&D
$3.6M$6.5M
SG&A
$42.9M$30.2M
Operating Income
-$58.2M-$40.7M
Interest Expense
$2.5M$2.0M
Pretax Income
-$62.1M-$45.9M
Net Income
-$62.1M-$45.9M
EPS (Diluted)
-3.23-2.05
EBITDA
-$59.6M-$41.7M
Shares Out. (M)
19.2125.78

Balance Sheet

MetricTrend2025TTM
Cash & Equivalents
$58.7K$6.2M
Short-Term Investments
$0.00$0.00
Total Current Assets
$1.4M$8.5M
Total Assets
$2.8M$9.3M
Total Current Liabilities
$20.0M$22.2M
Long-Term Debt
$0.00$235.2K
Total Liabilities
$20.3M$22.5M
Stockholders' Equity
-$17.5M-$13.2M
Retained Earnings
-$112.8M-$140.3M

Cash Flow Statement

MetricTrend2025TTM
Operating Cash Flow
-$20.4M-$20.4M
Capital Expenditure
-$500.0K$0.00
Free Cash Flow
-$20.9M-$20.4M
Investing Cash Flow
-$500.0K$0.00
Financing Cash Flow
$20.9M$25.6M
Issuance of Stock
$17.2M$2.8M
Repurchase of Stock
$0.00$0.00
Net Debt Issuance
$3.7M-$6.7M
Stock Based Comp.
$35.6M$18.2M
Net Change in Cash
-$6.2K$5.2M

Dilution Tracker

Shares Outstanding
29M
5-Year Share Growth
+0.0%
Stock Issuance (TTM)
$2.8M
MetricTrend2025TTM
Shares Out. (M)
19.2125.78
Change vs Prior %—34.2%
Stock Issuance
$17.2M$2.8M
Stock Repurchase
$0.00$0.00
Stock Based Comp.
$35.6M$18.2M

Margins & Profitability

MetricTrend2025TTM
Gross Margin %100.0%—
Operating Margin %-145459.4%—
Net Margin %-155404.4%—
EBITDA Margin %-149050.2%—
FCF Margin %-52172.9%—
ROE %
355.0%293.8%
ROA %
-2200.9%-492.9%
ROIC %
519.7%316.1%
R&D / Revenue %9097.9%—

Valuation

P/E (TTM)At Loss
P/S0.00
P/B-6.83
EV/EBITDAAt Loss
EV/Revenue0.00
P/FCFAt Loss

Intrinsic Value Models (per share)

Cash / Share
$0.24
MetricTrend2025TTM
P/E Ratio
-2.56-1.70
P/S Ratio
3973.020.00
P/B Ratio
-9.07-6.83
EV/EBITDA
-2.77-2.27
EV/Revenue
4129.440.00

Analyst Estimates & Quality

Altman Z-Score
-35.02
Distress
Piotroski F-Score
3
Weak

Forward Estimates (consensus)

MetricFY2026FY2027FY2028
Revenue$40.0K$40.0K$40.0K
Net Income-$32.2M-$31.2M-$21.0M
EPS$-1.39$-1.11$-1.09
# Analysts (EPS)342